Beskrivning av upphandlingen
The department of Laboratory Medicine at Lund University, Sweden is acquiring a Flow cytometry Analyzer. The equipment is intended to be used for the development and completion of experimental proof-of-concept of a cancer immunotherapy based on the cell fate reprogramming of cancer cells to dendritic cells. This project will be developed at the Cell Reprogramming in Hematopoiesis and Immunity Lab, Division of Molecular Medicine and Gene Therapy, Department of Laboratory Medicine at Lund University.